Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakashita, Y; Yamamoto, T1

Other Studies

1 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

ArticleYear
COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA.
    Neuroreport, 1998, Dec-01, Volume: 9, Issue:17

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Indomethacin; Injections, Spinal; Isoenzymes; Male; N-Methylaspartate; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonamides

1998